Pricing Log in Create free account

Heron Therapeutics, Inc. (HRTX) vs OKYO Pharma Limited Sponsored ADR (OKYO)

Heron Therapeutics, Inc. and OKYO Pharma Limited Sponsored ADR are both Biotechnology companies. Heron Therapeutics, Inc. and OKYO Pharma Limited Sponsored ADR are of similar size ($75.1M and $71.5M). OKYO Pharma Limited Sponsored ADR has the higher net margin (0.00% vs −22.5%) and the higher return on invested capital (0.00% vs −6.35%). Across the 13 metrics below, OKYO Pharma Limited Sponsored ADR leads on 7 and Heron Therapeutics, Inc. on 6.

Valuation

Metric HRTX OKYO Biotechnology median
P/E n/m n/m 8.50
P/S 0.45 n/m 9.71
P/B 11.70 86.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.11 n/m 9.21
Earnings yield (52.78%) 0.00% (33.15%)
Free cash flow yield (17.64%) (0.89%) (25.50%)

Profitability

Metric HRTX OKYO Biotechnology median
Gross margin 70.07% 0.00% 65.16%
Operating margin (7.19%) — 0.00%
Net margin (22.52%) 0.00% 0.00%
Free cash flow margin (8.00%) 0.00% 0.00%
Return on equity 318.21% 0.00% (56.36%)
Return on assets (14.06%) 0.00% (48.04%)
Return on invested capital (6.35%) 0.00% 0.00%

Growth

Metric HRTX OKYO Biotechnology median
Revenue growth (TTM) 0.99% — 6.02%
EPS growth (last fiscal year) (33.33%) (101.34%) 30.26%
Revenue growth, 5-year CAGR 11.81% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX OKYO Biotechnology median
Debt to equity 20.65 0.00 0.00
Current ratio 2.49 2.43 4.72
Net debt to EBITDA (643.88) 2.42 0.96

Dividend

Metric HRTX OKYO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HRTX OKYO Biotechnology median
Market cap 71.48m 75.05m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack